Ten–eleven translocase: key regulator of the methylation landscape in cancer Jyoti ShekhawatKavya GaubaMithu Banerjee Review – Cancer Research 28 April 2021 Pages: 1869 - 1879
New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression Qingkang MengYan ZhangXiujie Chen Original Article – Cancer Research 11 March 2021 Pages: 1881 - 1895
Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience Giada MunariGianluca BusinelloMatteo Fassan Original Article – Cancer Research Open access 12 March 2021 Pages: 1897 - 1904
Combining radiation to EGFR and Bcl-2 blockade: a new approach to target cancer stem cells in head and neck squamous cell carcinoma Jean-Baptiste GuySophie EspenelNicolas Magné Original Article – Cancer Research 31 March 2021 Pages: 1905 - 1916
Dietary supplement use in ambulatory cancer patients: a survey on prevalence, motivation and attitudes Maja TankKristina FranzKristina Norman Original Article – Cancer Research Open access 06 April 2021 Pages: 1917 - 1925
The peptide mimicking small extracellular ring domain of CD82 inhibits tumor cell migration in vitro and metastasis in vivo Xin HeXiaoguang MaKeli Ma Original Article – Cancer Research 02 April 2021 Pages: 1927 - 1934
Correction to: The peptide mimicking small extracellular ring domain of CD82 inhibits tumor cell migration in vitro and metastasis in vivo Xin HeXiaoguang MaKeli Ma Correction 05 May 2021 Pages: 1935 - 1935
Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients Paulina Karin GrilloBalázs GyőrffyMartin Götte Original Article – Cancer Research Open access 19 March 2021 Pages: 1937 - 1955
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment Stefano MartellucciLetizia ClementiAdriano Angelucci Original Article – Cancer Research Open access 02 April 2021 Pages: 1957 - 1971
NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers Chrissie E. B. OngAmanda L. PatchettAndrew S. Flies Original Article – Cancer Research 02 April 2021 Pages: 1973 - 1991
CCL5 production by fibroblasts through a local renin–angiotensin system in malignant melanoma affects tumor immune responses Kenta NakamuraYukiko KiniwaRyuhei Okuyama Original Article – Cancer Research 26 March 2021 Pages: 1993 - 2001
The association between the expression of PD-L1 and CMTM6 in undifferentiated pleomorphic sarcoma Shin IshiharaTakeshi IwasakiYoshinao Oda Original Article – Cancer Research 03 April 2021 Pages: 2003 - 2011
Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT Yao ZhaoChenchen CaiShibao Li Original Article – Cancer Research 27 March 2021 Pages: 2013 - 2023
Selinexor decreases HIF-1α via inhibition of CRM1 in human osteosarcoma and hepatoma cells associated with an increased radiosensitivity Moritz von FalloisFriederike Katharina KosynaReinhard Depping Original Article – Cancer Research Open access 15 April 2021 Pages: 2025 - 2033
Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review D. HuberS. SeitzO. Ortmann Review – Clinical Oncology Open access 22 April 2021 Pages: 2035 - 2045
Significance of boost dose for T4 nasopharyngeal carcinoma with residual primary lesion after intensity-modulated radiotherapy Zhaodong FeiTing XuChuanben Chen Original Article – Clinical Oncology 03 January 2021 Pages: 2047 - 2055
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach Luca BoldriniAngela RomanoVincenzo Valentini Original Article – Clinical Oncology 04 January 2021 Pages: 2057 - 2068
Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study) Fiorenza De RoseMaria Carmen De SantisMarta Scorsetti Original Article – Clinical Oncology 02 January 2021 Pages: 2069 - 2077
Network pharmacology-based and clinically relevant prediction of active ingredients and potential targets of Chinese herbs on stage IV lung adenocarcinoma patients Jinfeng LiuJian HaoXiongzhi Wu Original Article – Clinical Oncology 02 April 2021 Pages: 2079 - 2092
Take care or “German Angst”? Lessons from cancer care during COVID-19 pandemic in spring 2020 Jens BüntzelOliver MickeJutta Huebner Original Article – Clinical Oncology 02 January 2021 Pages: 2093 - 2105
Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases Dao-Ping SunWen-Ming ChenJian-Yong Li Original Article – Clinical Oncology Open access 05 February 2021 Pages: 2107 - 2115
Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer center Marie-Kristin SchwaegermannMelanie SchranzGeorg Hess Original Article – Clinical Oncology Open access 09 January 2021 Pages: 2117 - 2126
Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study Chuanxi ZhengJianguo FangLi Min Original Article – Clinical Oncology 15 January 2021 Pages: 2127 - 2135
Secondary esophageal squamous cell carcinoma after hematopoietic stem cell transplantation Kosuke NomuraToshiro IizukaShu Hoteya Original Article – Clinical Oncology 02 January 2021 Pages: 2137 - 2144
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study Burak BilginMehmet Ali Nahit SendurBulent Yalcin Original Article – Clinical Oncology 12 January 2021 Pages: 2145 - 2152
Surgical and oncological efficacy of laparoscopic-assisted total gastrectomy versus open total gastrectomy for gastric cancer by propensity score matching: a retrospective comparative study Yingcong FanMaoxing LiuXiangqian Su Original Article – Clinical Oncology Open access 07 January 2021 Pages: 2153 - 2165
Elotuzumab spares dendritic cell integrity and functionality Sebastian SchlaweckLeon StraussAnnkristin Heine Letter to the Editor Open access 02 March 2021 Pages: 2167 - 2170
Letter regarding, “Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses” Aayah NounuVenexia WalkerRebecca C. Richmond Letter to the Editor 12 January 2021 Pages: 2171 - 2173
Correction to: Letter regarding, “Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses” Aayah NounuVenexia WalkerRebecca C. Richmond Correction 11 April 2021 Pages: 2175 - 2175
